CDC6 as a pan-cancer immunological and prognostic biomarker and its role in suppressing melanoma malignancy
Abstract Background: Cell division cycle 6 (CDC6) is a key licensing factor for DNA replication in the G1 and S…
Qian Wu
Potential for Therapeutic Alteration of the Underlying Biology of Epilepsy
Abstract Approximately 30–35% of people with epilepsy experience seizures despite taking antiseizure medications. Recurrent seizures that are independent of status…
An integrative pan-cancer bioinformatics analysis of MSRB1 and its association with tumor immune microenvironment, prognosis, and immunotherapy
Abstract Methionine sulfoxide reductase B1 (MSRB1) is involved in the development and immune regulation of multiple tumors. However, the role…
Identification of hub genes in papillary thyroid carcinoma: robust rank aggregation and weighted gene co-expression network analysis
Abstract Background: Papillary thyroid carcinoma (PTC), which is the most common endocrine malignancy, has been steadily increasing worldwide in incidence…